Atlas Trials

Squalamine for the Treatment in Proliferative Diabetic Retinopathy

Clinical trial NCT01769183 · COMPLETED

Trial details

NCT number
NCT01769183
Sponsor
Elman Retina Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Retinal Neovascularization
Start date
2013-02-01
Primary completion
2014-08-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.